Siste oppdatering :
Stabilitet og kompatibilitet av legemidler
Velkommen som Stabilisbruker. Ønsker du å motta Stabilis’ nyhetsbrev hvert kvartal, vennligst fyll inn din e-postaddresse. Melde deg på

Ved spørsmål eller kommentarer, vennligst kontakt :
Referanser : 2758
Legemiddel : 855
Farmakologisk klasse : 46
Oppløsningsstabilitet : 6301
Stabilitet i blandinger : 1245
Kompatibilitet : 12267
Handelsnavn : 4983
Jaunumi - Legemiddel  
Antiviralt middel Injeksjon Remdesivir 13/09/2023
Neuroleptika Mikstur Lurasidone 28/08/2023
Forskjellig Kapsel Cholic acid 12/06/2023
Forskjellig Mikstur L-Methionine 22/05/2023
Generell anestesi Stikkpille Pentobarbital 22/05/2023
Antibiotika Kapsel Erythromycine 22/05/2023
Antiviralt middel Øyedråper Ganciclovir 02/03/2023
Anxiolytika Injeksjon Remimazolam 28/02/2023
Forskjellig Injeksjon Teduglutide 24/02/2023
Forskjellig Salver Resorcinol 19/01/2023
Antihypertensiva Kapsel Clonidine hydrochloride 05/12/2022
Antibiotika Injeksjon Omadacycline 20/11/2022
Kreft narkotika Injeksjon Trastuzumab deruxtecan 17/11/2022
Kreft narkotika Mikstur Vinorelbine 05/11/2022
Antibiotika Injeksjon Cefradine 06/09/2022
Forskjellig Injeksjon Ambroxol 06/09/2022
Generell anestesi Injeksjon Esketamine 01/09/2022
Kreft narkotika Injeksjon Melphalan captisol 01/09/2022
Antibiotika Injeksjon Mezlocilline 01/09/2022
Kreft narkotika Mikstur Ruxolitinib 28/06/2022
Jaunumi - Referanser  
Dato for Entry
4784 In-use stability of ready-to- administer daratumumab subcutaneous injection solution in plastic syringes. EJHP 04/11/2023
4785 Darzalex 1800 mg solution for injection - Summary of Product characteristics. Janssen-Cilag International NV 04/11/2023
4780 Extemporaneous Topical Minoxidil Solutions for the treatment of Alopecia : Stability Studies and Incorporation Tests of Active Ingredients in ALOPLUS FAST Base. Int J Pharm Compound 13/09/2023
4777 Physicochemical and microbiological stability of azathioprine suspensions in PCCA base Suspendit. Int J Pharm Compound 08/09/2023
4770 Use of a liquid chromatography-tandem mass spectrometry method to assess the concentration of epinephrine, norepinephrine, and phenylephrine stored in plastic syringes. Pharmaceutical Technology in Hospital Pharmacy 22/08/2023
4767 Physicochemical stability of durvalumab (Imfinzi® ) concentrate for solution in original vials after first opening. Pharmaceutical Technology in Hospital Pharmacy 02/08/2023
4763 Physicochemical stability of urea-containing Mitomycin C preparations in glass vials (1.0 mg/mL) and plastic syringes (2.0, 0.4, 0.2 mg/mL) Pharmaceutical Technology in Hospital Pharmacy 02/08/2023
4766 Stability of omeprazole extemporaneous oral solution in Chopin Base. Int J Pharm Compound 02/08/2023
4768 Y-site injection physical compatibility of remdesivr with select intravenous drugs used in palliative care and for treating coronavirus disease 2019. Journal of Nippon Medical school 02/08/2023
4769 Cisatracurium Besylate 10 mg/mL Solution Compounded in a Hospital Pharmacy to Prevent Drug Shortages : A Stability Study Involving Four Degradation Products. Pharmaceutics 02/08/2023
4762 Physicochemical stability of carmustine-containing medicinal products after reconstitution and after dilution to ready-to-administer infusion solutions stored refrigerated or at room temperature EJHP 01/08/2023
4761 Physicochemical stability of Cabazitaxel Zentiva® solution in vials after opening and diluted- solutions in three infusion bags. Pharmaceutical Technology in Hospital Pharmacy 28/07/2023
4759 Stability of 5-fluorouracil at 4°C, 25°C, and 33°C stored in NiproSureFuser+ Ambulatory Balloon Infusers. Sunnybrook Healt Science Centre 10/07/2023
4757 In Vitro Assessment of Compounded Lurasidone Suspensions for Enteral Feeding Tubes. Hosp Pharm 06/06/2023
4756 Physicochemical stability of PF-06439535 (bevacizumab-bvzr; Zirabev®), a bevacizumab biosimilar, under extended in-use conditions. J Oncol Pharm Practice 16/05/2023
4755 Extended physicochemical stability of cetuximab in opened vials and infusion bags when stored at 4°C and 25°C. J Oncol Pharm Practice 03/05/2023
4754 Physicochemical stability of PF-05280014 (trastuzumab-qyyp; TrazimeraTM), a trastuzumab biosimilar, under extended in-use conditions. J Oncol Pharm Practice 26/04/2023
4747 Pharmaceutical Oral Formulation of Methionine as a Pediatric Treatment in Inherited Metabolic Disease. Pharmaceutics 24/04/2023
4748 Physicochemical Stability of Generic Thiotepa Concentrate and Ready-to-Administer Infusion Solutions for Conditioning Treatment. Pharmaceutics 24/04/2023
4750 Development and Stability of a New Formulation of Pentobarbital Suppositories for Paediatric Procedural Sedation. Pharmaceutics 24/04/2023
4751 Product Validation and Stability Testing of Pharmacy Compounded Cholic Acid Capsules for Dutch Patients with Rare Bile Acid Synthesis Defects. Pharmaceutics 24/04/2023
4746 Stability and Compatibility of Bupivacaine and Hydromorphone in PVC and non-DEHP bags for 30 days at 4°C and 25°C. 14/04/2023
4744 Stability Report of Extended SB8 Opened Vial (400 mg) Stability. 07/04/2023
4745 Physicochemical stability study of a biosimilar of Bevacizumab in vials and after dilution in 0.9% NaCl in polyolefin intravenous bags. Pharmaceutical Technology in Hospital Pharmacy 07/04/2023
4742 Compatibilité physique de l’acétaminophène injectable avec 102 autres médicaments lors d’une administration en Y. Pharmactuel 02/04/2023
4741 Physicochemical and Microbiological Stability of Pyrimethamine in Paraben-free PCCA Base, SuspendIt. Int J Pharm Compound 29/03/2023
4740 MabThera 500 mg concentrate for solution for infusion. Summary of Product Characteristics Updated 07-Oct-2021 Roche Products Limited 06/03/2023
4737 Extended Stability of Isoproterenol Hydrochloride Injection in Polyvinyl Chloride Bags Stored in Amber Ultraviolet Light Blocking Bags. Hosp Pharm 04/03/2023
4739 Low-dose erythromycin in pediatrics: Formulation and stability of 20 mg hard gelatin capsules. PlosOne 04/03/2023
4736 An Ultra-High-Performance Chromatography method to study the long term stability of gemcitabine in dose banding conditions. J Pharm Biomed Anal 20/02/2023

  Mentions Légales